- B2B
- Growth StageExpanding market presence
Thalamus Funding
$0
22 rounds
Thalamus is active in the following markets / industries: SaaS, enterprise software, health care and education. The company has secured funding across 2 rounds and is valued at $0. Their most recent funding was raised on December 12, 2019.
Funding Rounds
PRE
$600000Investors of Thalamus
Dr. Paul Bigeleisen, Professor of Anesthesiology and Adjunct Professor of Bioengineering, University of Maryland
